Skip to content

Stock-Based Comp at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$146M+1.4%
Merck & Co. logo
Merck & Co.MRK
$185M-5.1%
United Therapeutics logo
United TherapeuticsUTHR
$33.9M+6.6%
Rein Therapeutics, Inc. Common Stock logo
Rein Therapeutics, Inc. Common StockRNTX
$156K-40.9%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$6.9M+5.2%
Design Therapeutics, Inc. logo
Design Therapeutics, Inc.DSGN
$3.92M+10.9%

Other financials

Income statement

See full
Revenue-
Operating income-$11.4M+27.5%
Net income-$10.8M+27.5%
EPS (diluted)-$0.11+35.3%

Balance sheet

See full
Cash & equivalents$10.0M-3.4%
Total debt$12.3M-9.2%
Total equity$57.9M-22.8%
Total assets$79.7M-18.1%

Cash flow

See full
Operating cash flow-$12.5M+18.8%
CapEx$138.0K
Free cash flow-$12.7M+17.9%

Valuation

See full
Market cap$1.14B+30.5%
Enterprise value$1.15B
P/S6,014.3×

Profitability

See full
Operating margin-40,856.3%+28,833pp
Net margin-39,009.5%+29,653pp
FCF margin-32,664.7%+4,018pp

Returns & leverage

See full
Return on equity-105.3%+50.6pp
Debt / equity0.2×0.0×
Current ratio5.8×-2.0×

Where this comes from

Reported directly by Ethos Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.

The official record: Ethos Technologies, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ethos Technologies, Inc. 's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ethos Technologies, Inc. 's stock-based comp?
Ethos Technologies, Inc. (LIFE) reported stock-based comp of $1.31M in Q1 2026.
How has Ethos Technologies, Inc. 's stock-based comp changed year-over-year?
Ethos Technologies, Inc. 's stock-based comp increased by 11.0% year-over-year, from $1.18M to $1.31M.
What is the long-term trend for Ethos Technologies, Inc. 's stock-based comp?
Over 4 years (2021 to 2025), Ethos Technologies, Inc. 's stock-based comp has grown at a 32.6% compound annual growth rate (CAGR), from $1.61M to $5M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.